Testing effectiveness (Phase 2)Study completedNCT00831922What this trial is testingEfficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis AB Science 43
Testing effectiveness (Phase 2)Study completedNCT02799472What this trial is testingMechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid ArthritisWho this might be right forArthritis, Rheumatoid GlaxoSmithKline 39
Not applicableStudy completedNCT01874977What this trial is testingTrial of a Physical Activity Intervention for RA FatigueWho this might be right forRheumatoid Arthritis University of California, San Francisco 96
Testing effectiveness (Phase 2)Study completedNCT00902486What this trial is testingINCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic DrugsWho this might be right forRheumatoid Arthritis Incyte Corporation 127
Early research (Phase 1)Looking for participantsNCT07207954What this trial is testingStudy of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Lifordi Immunotherapeutics, Inc. 176
Testing effectiveness (Phase 2)Ended earlyNCT01862224What this trial is testingA Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyWho this might be right forRheumatoid Arthritis Janssen Research & Development, LLC 21
Not applicableUnknownNCT05422313What this trial is testingAssessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease ActivityWho this might be right forRheumatoid Arthritis Assiut University 86
Testing effectiveness (Phase 2)Ended earlyNCT05516758What this trial is testingPeresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisWho this might be right forRheumatoid ArthritisArthritisJoint Diseases+5 more Eli Lilly and Company 491
Testing effectiveness (Phase 2)Study completedNCT01960855What this trial is testingA Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyWho this might be right forRheumatoid Arthritis AbbVie 276
Testing effectiveness (Phase 2)UnknownNCT01552538What this trial is testingLong Term Extension Study For SPM-005 ParticipantsWho this might be right forRheumatoid Arthritis SetPoint Medical Corporation 18
Large-scale testing (Phase 3)Study completedNCT02067910What this trial is testingEfficacy and Safety of Abatacept in Patients With Primary Sjögren's SyndromeWho this might be right forSjögren's Syndrome University Medical Center Groningen 80
Large-scale testing (Phase 3)Study completedNCT00973479What this trial is testingAn Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyWho this might be right forArthritis, Rheumatoid Centocor, Inc. 592
Testing effectiveness (Phase 2)Study completedNCT01313520What this trial is testingEvaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)Who this might be right forArthritis, Rheumatoid Merck Sharp & Dohme LLC 61
Post-approval studies (Phase 4)Study completedNCT00807846What this trial is testingEvaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric SubjectsWho this might be right forArthritis, Juvenile Rheumatoid Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 201
Testing effectiveness (Phase 2)Ended earlyNCT02151474What this trial is testingINCB047986 in Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Incyte Corporation 3
Testing effectiveness (Phase 2)Ended earlyNCT01636817What this trial is testingA Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa BiologicsWho this might be right forInflammationRheumatoid Arthritis Novo Nordisk A/S 239
Not applicableUnknownNCT04768413What this trial is testingEvaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Fundación Universitaria de Ciencias de la Salud 200
Large-scale testing (Phase 3)Study completedNCT00996606What this trial is testingTocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDsWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00595413What this trial is testingAtacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)Who this might be right forRheumatoid Arthritis EMD Serono 311
Testing effectiveness (Phase 2)Study completedNCT01590459What this trial is testing24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking MethotrexateWho this might be right forRheumatoid Arthritis Vertex Pharmaceuticals Incorporated 359